Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
出版年份 2012 全文链接
标题
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
作者
关键词
-
出版物
BMC Medicine
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-03-20
DOI
10.1186/1741-7015-10-20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
- (2011) Marie-Christine Chartier-Harlin et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson’s disease-associated protein
- (2011) HyeJin Yun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genome-wide association study confirms extant PD risk loci among the Dutch
- (2011) Javier Simón-Sánchez et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
- (2011) Martin C. Herzig et al. HUMAN MOLECULAR GENETICS
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- The association between Parkinson's disease and melanoma
- (2011) Tianhong Pan et al. INTERNATIONAL JOURNAL OF CANCER
- Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
- (2011) Diane Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
- (2011) Philip J. Webber et al. JOURNAL OF MOLECULAR BIOLOGY
- A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
- (2011) J. Dusonchet et al. JOURNAL OF NEUROSCIENCE
- The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from Southern Italy
- (2011) Chiara Criscuolo et al. MOVEMENT DISORDERS
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
- (2011) David Ramonet et al. PLoS One
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- Genome-Wide Association Study Confirms SNPs inSNCAand theMAPTRegion as Common Risk Factors for Parkinson Disease
- (2010) Todd L. Edwards et al. ANNALS OF HUMAN GENETICS
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2)
- (2010) Brian Lovitt et al. BIOCHEMISTRY
- Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities
- (2010) Min Liu et al. BIOCHEMISTRY
- Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population
- (2010) M. Saad et al. HUMAN MOLECULAR GENETICS
- Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
- (2010) Veronique Daniëls et al. JOURNAL OF NEUROCHEMISTRY
- LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3
- (2010) C.-H. Lin et al. JOURNAL OF NEUROSCIENCE
- LRRK2G2019S mutations are associated with an increased cancer risk in Parkinson disease
- (2010) Rachel Saunders-Pullman et al. MOVEMENT DISORDERS
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
- (2010) Jan O. Aasly et al. MOVEMENT DISORDERS
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
- (2010) Taye H Hamza et al. NATURE GENETICS
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- (2010) Byoung Dae Lee et al. NATURE MEDICINE
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
- (2010) B. Winner et al. NEUROBIOLOGY OF DISEASE
- Gene–environment interactions in Parkinson's disease and other forms of parkinsonism
- (2010) Jeffery M. Vance et al. NEUROTOXICOLOGY
- The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation
- (2010) Azad Kumar et al. PLoS One
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice
- (2010) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions?
- (2010) Nir London et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
- (2009) Elisa Greggio et al. ASN Neuro
- The R1441C mutation alters the folding properties of the ROC domain of LRRK2
- (2009) Yongchao Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Caenorhabditits elegansLRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth
- (2009) Julia Sämann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
- (2009) Luke S Tain et al. NATURE NEUROSCIENCE
- It takes two to tango: regulation of G proteins by dimerization
- (2009) Raphael Gasper et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spain
- (2009) Ignacio F. Mata et al. NEUROGENETICS
- Clinical features of LRRK2 parkinsonism
- (2009) Kristoffer Haugarvoll et al. PARKINSONISM & RELATED DISORDERS
- The WD40 Domain Is Required for LRRK2 Neurotoxicity
- (2009) Nathan D. Jorgensen et al. PLoS One
- Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
- (2008) Jason P. Covy et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
- Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients
- (2008) Karen Nuytemans et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson’s disease
- (2008) J. C. Möller et al. EUROPEAN JOURNAL OF NEUROLOGY
- Investigation of leucine-rich repeat kinase 2
- (2008) Vasanti S. Anand et al. FEBS Journal
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
- (2008) Edward D. Plowey et al. JOURNAL OF NEUROCHEMISTRY
- LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study
- (2008) Mary M Hulihan et al. LANCET NEUROLOGY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay
- (2008) Ignacio F. Mata et al. PARKINSONISM & RELATED DISORDERS
- Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
- (2008) Kazuko Hasegawa et al. PARKINSONISM & RELATED DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now